ESMO 2023 Insights: "Comparing Belzutifan With Everolimus in Pretreated Advanced Clear Cell RCC - Results From LITESPARK-005 Study" | VuMedi

Find latest Renal Cell Carcinoma videos · 200+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

ecancer

ESMO 2023 Insights: "Comparing Belzutifan With Everolimus in Pretreated Advanced Clear Cell RCC - Results From LITESPARK-005 Study"

By ecancer FEATURING Toni Choueiri

By ecancer FEATURING Toni Choueiri

72 views

October 25, 2023

Comments 0

Login to view comments. Click here to Login